Amphiphilic Shuttle Peptide Enables the Development of PMO-based Therapeutics to Treat Basal Cell Carcinoma and Muco-obstructive Lung Diseases
Tides 2027 · 29 April 2027 · 10:45–11:15
Amphiphilic Shuttle Peptide Enables the Development of PMO-based Therapeutics to Treat Basal Cell Carcinoma and Muco-obstructive Lung Diseases was a session at Tides 2027 on 29 April 2027 in Boston.